Dynamic Dashboard

The Global AMR R&D Hub’s Dynamic Dashboard continuously collects and presents information on more than 8 bn USD AMR R&D investments from across the One Health continuum – human, animal, plant and environment. It also presents information on antibacterial products in the clinical development pipeline and incentives for antibiotic R&D.

Public and philanthropic investments in AMR R&D related to animal health vaccines

30.08.2021: Antimicrobial resistance (AMR) not only poses a global threat to public health but also has severe implications for the health and welfare of animal populations. We are pleased to publish a new report that focuses on the current state of R&D funding for animal health vaccine...

Study Publication: Estimating global market potential for priority health technologies addressing AMR

19.08.2021: One of the challenges inhibiting a more unified and co-ordinated global action in the field of AMR product development incentives is a lack of evidence or data to quantify the need or size of the challenge and therefore the scale of the required intervention. A multidiscipli...

New collaboration between ICARS and the Global AMR R&D Hub

The Global AMR R&D Hub and ICARS are pleased to announce a new partnership that will further strengthen their efforts to translate evidence into action to mitigate antimicrobial resistance (AMR). The collaboration will harness the power of the Global AMR R&D Hub’s Dynamic Dashboard ...

Funded by:
Federal Ministry of Health
Federal Ministry of Education and Research